Delcath Systems Inc. (DCTH) Hits New 12-Month High at $3.79
Delcath Systems Inc. (NASDAQ:DCTH) reached a new 52-week high during trading on Thursday . The company traded as high as $3.79 and last traded at $3.47, with a volume of 50,945 shares trading hands. The stock had previously closed at $0.26.
The stock has a 50 day moving average of $4.09 and a 200-day moving average of $4.89. The stock’s market cap is $86.82 million.
Delcath Systems (NASDAQ:DCTH) last announced its quarterly earnings results on Wednesday, May 4th. The medical device company reported ($0.08) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.11. On average, equities analysts anticipate that Delcath Systems Inc. will post ($7.84) earnings per share for the current year.
Delcath Systems, Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS).
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.